. Age-standardized mortalities from colon cancer in USA, Japan and Korea. The Age-standardized mortalities from colon cancer in the USA show decreases since the mid 1980's in both sexes. In Japan, there have also been decreases in mortality from colon cancer since the mid 1990's. However, rates are continuing to increase in South Korea (Base line data from Ref. 42).
Lynch syndrome is the most common familial colorectal cancer syndrome. It is linked to germline mutations in one of four DNA mismatch repair (MMR) genes. A comprehensive family history is one important way to identify at-risk individuals. The elucidation of the molecular genetics of this syndrome has made it possible to screen for the disorder with molecular tests. Microsatellite instability and/or immunohistochemistry followed by germline testing for mutations in MMR genes is now a standard approach for clinically suspected cases. Correctly recognizing Lynch syndrome is essential for the application of appropriate screening and surveillance measures. Close surveillance and risk-reducing operations can decrease cancer-related mortality. In addition, counseling is an important component of the management of any family with Lynch syndrome. (Gut Liver 2010;4:151-160)
INTRODUCTION
Colorectal cancer is the second leading cause of cancer-related death in the United States, with approximately 140,000 cases diagnosed and 50,000 deaths annually. Recently, an increasing incidence has also been observed in many Asian countries. In Korea, there were 19,570 new cases diagnosed in 2006, making it the 3rd most common cancer diagnosed. That year, there were 6,277 deaths attributable to colon cancer, making it the 4th leading cause of cancer-related deaths in Korea (Fig. 1) .
The majority of colorectal cancer cases are sporadic, occurring in individuals without any known familial predisposition. Approximately 10-30% of all cases occur in the context of a family history, but most of the predisposing genetic factors have not yet been identified. Highly penetrant inherited colorectal cancer syndromes such as familial adenomatous polyposis (FAP), MYH-associated polyposis (MAP), and Lynch syndrome/hereditary nonpolyposis colon cancer (HNPCC) are less common, but account for as many as 5% of all colorectal cancer cases. These syndromes can be divided into "polyposis"and "nonpolyposis" syndromes (Fig. 2) . The polyposis syndromes can be broadly classified as adenomatous polyposis syndromes, hamartomatous polyposis syndromes, and the hyperplastic polyposis syndrome. Familial adenomatous polyposis (FAP) is an autosomal dominantly inherited disorder due to germline mutations in the APC gene. It is characterized by the emergence of hundreds to thousands of colorectal adenomatous polyps during the second or third decade of life. The incidence of FAP is between one in 5,000 to 7,500 individuals, and it manifests equally in both sexes. Left untreated, colorectal adenocarcinoma will develop in 100% of cases by age 50 years, or approximately 10-15 years after the initial appearance of polyposis. In addition to colorectal cancer, there is a strong predilection for other malignancies, in-
